thymoquinone has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachanova, V; Dou, L; Liu, S; Pang, J; Seiler, CL; Shen, N; Tretyakova, NY; Weaver, E; Wu, LC; Yan, F; Yang, K; Yu, L; Zhao, N | 1 |
| El-Hayek, S; Hodroj, MH; Khalife, R; Rizk, S; Stephany, el-H; Tarras, O | 1 |
2 other study(ies) available for thymoquinone and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells.
Topics: Animals; Benzoquinones; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Mice; Molecular Docking Simulation; Xenograft Model Antitumor Assays | 2017 |
Antiproliferative and proapoptotic effects of topotecan in combination with thymoquinone on acute myelogenous leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Leukemia, Myeloid, Acute; Signal Transduction; Topoisomerase I Inhibitors; Topotecan | 2014 |